Dr Lal Pathlabs Ltd

LALPATHLAB

Watchlist

AI Mode

‌

Market Cap

₹ 23,941 Cr

P/E

44.81

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Dr. Lal PathLabs is a leading diagnostic healthcare service provider in India, offering over 5000 tests through a vast network of laboratories nationwide.

The company has reported strong financial performance in Q2 FY26, with a revenue increase of 10.7% YoY and a PAT growth of 16.4%, showcasing solid operational efficiency.

Dr. Lal PathLabs has pioneered the use of AI in diagnostics, becoming the first lab in India to utilize AI for cancer detection, enhancing speed and accuracy in oncology reporting.

The company is expanding its reach into Tier-3 and Tier-4 towns, anticipating future scalability, supported by its franchise-led network model.

Notably, the company has announced an ambitious genomics and sequencing technology strategy, positioning itself for future market opportunities in advanced diagnostics.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

23,941 Cr

Volatility

Low Risk

P/E Ratio

44.8

Industry P/E

48.3

PEG Ratio

4.8

P/B Ratio

10.0

52W High

3,542.60

52W Low

2,295.10

Sales CAGR

10.54%

7.77%

13.05%

10Y

13.28%

Profit CAGR

35.87%

12.93%

17.38%

10Y

16.50%

ROE

TTM

22.38%

18.71%

19.99%

10Y

20.70%

ROCE

TTM

27.37%

25.13%

26.22%

10Y

28.01%

Technicals

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Forecasts

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Dec 03, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
LALPATHLAB	2854.15	23,941 Cr	44.81	10.03	0.84	22.38	27.37	18.24
VIJAYA	984.75	10,162 Cr	66.66	11.75	0.20	17.53	18.98	10.93
METROPOLIS	1917.10	9,939 Cr	62.82	6.94	0.00	11.05	14.12	7.97
THYROCARE	434.90	6,880 Cr	53.83	12.88	1.62	23.91	34.14	18.61
VIMTALABS	611.90	2,719 Cr	44.73	7.93	0.16	14.59	19.04	13.94
KRSNAA	742.75	2,428 Cr	28.71	2.63	0.37	9.16	11.09	5.61
SURAKSHA	285.60	1,485 Cr	46.53	6.45	0.00	13.86	14.74	8.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	541	601	539	545	602	660	597	603	670	731
Expenses	395	424	398	401	432	458	443	434	478	507
Operating Profit	146	178	141	145	170	203	154	169	192	224
OPM %	27.02	29.57	26.09	26.53	28.24	30.67	25.81	28.05	28.71	30.67
Other Income	14	18	18	18	21	22	25	26	28	25
Interest	8.00	7.80	7.00	6.60	6.00	6.00	5.30	5.00	4.70	4.80
Depreciation	35	36	36	37	35	35	36	36	35	41
Profit Before Tax	118	152	116	120	150	183	138	153	181	204
Tax %	28.85	27.27	29.08	28.44	28.09	28.56	29.07	-1.37	26.01	25.25
Net Profit	84	111	82	86	108	131	98	156	134	152
EPS in Rs	9.89	13.07	9.73	10.08	12.72	15.44	11.55	18.50	15.85	18.05

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	912	1,057	1,203	1,330	1,581	2,087	2,017	2,227	2,461	2,529
Expenses	676	793	910	987	1,145	1,527	1,527	1,617	1,766	1,812
Operating Profit	237	264	294	344	436	561	490	609	696	718
OPM %	25.93	24.98	24.40	25.83	27.59	26.86	24.29	27.36	28.26	28.38
Other Income	25	31	46	55	51	53	42	69	93	101
Interest	0.21	0.84	0.84	15	16	30	38	29	22	21
Depreciation	28	33	38	73	77	108	150	144	142	142
Profit Before Tax	233	261	301	311	394	475	344	505	625	656
Tax %	33.48	34.27	33.30	26.70	24.83	26.25	29.88	28.32	21.21	20.96
Net Profit	155	172	200	228	296	350	241	362	492	518
EPS in Rs	18.60	20.73	24.05	27.22	35.05	41.36	28.59	42.77	58.21	63.95
Dividend Payout %	16.17	21.61	24.84	43.84	56.74	28.87	20.88	41.88	41.10	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	83	83	83	83	83	83	83	83	83	84
Reserves	425	577	705	862	949	1,162	1,418	1,583	1,766	2,089
Borrowings	0.00	0.00	0.00	0.00	0.00	150	533	419	247	157
Other Liabilities	118	104	128	145	341	266	313	300	360	387
Total Liabilities	625	764	916	1,091	1,374	1,661	2,347	2,386	2,456	2,717
Fixed Assets	166	190	208	209	413	447	1,369	1,305	1,194	1,135
CWIP	4.09	18	9.56	3.44	11	9.61	15	4.94	5.65	3.48
Investments	64	105	145	185	164	59	65	150	147	360
Other Assets	391	452	554	694	786	1,145	897	926	1,109	1,218
Total Assets	625	764	916	1,091	1,374	1,661	2,347	2,386	2,456	2,717

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	147	172	197	219	284	398	447	456	535	569
Cash from Investing Activity	-152	-141	-172	-100	-26	-212	-449	-287	-24	-303
Cash from Financing Activity	0.36	-34	13	-55	-190	-139	136	-283	-414	-334
Net Cash Flow	-4.59	-3.48	37	64	67	48	134	-114	97	-68

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	55.36%	55.32%	55.25%	54.83%	54.81%	54.78%	54.77%	54.10%	54.06%	54.05%	54.00%	53.41%
FIIs	25.95%	25.02%	23.37%	24.46%	25.45%	26.24%	25.50%	26.91%	26.89%	23.97%	21.77%	21.94%
DIIs	6.23%	6.59%	8.67%	9.18%	9.59%	9.72%	12.75%	12.93%	13.20%	16.12%	17.98%	18.55%
Public	12.47%	13.08%	12.71%	11.53%	10.15%	9.27%	6.98%	6.06%	5.84%	5.85%	6.25%	6.09%
Total Shareholders	1,79,636	1,80,163	1,74,444	1,60,679	1,49,901	1,46,741	1,31,189	1,16,606	1,16,236	1,15,699	1,18,656	1,12,703

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Dec 05, 2025	Dr. lal pathlabs employee wel...	Insider - Other	Disposal	709.73	0.05 Cr	686	0.00
Nov 13, 2025	Ved prakash goel	Insider - KMP	Acquisition	10.00	0.00 Cr	3,200	0.00
Nov 13, 2025	Dr. lal pathlabs employee wel...	Insider - Other	Disposal	10.00	0.00 Cr	3,200	0.00
Nov 11, 2025	Seema kochhar	Insider - Designated Person	Acquisition	10.00	0.00 Cr	950	0.00
Nov 11, 2025	Dr. lal pathlabs employee wel...	Insider - Other	Disposal	436.71	0.06 Cr	1,436	0.00
Nov 06, 2025	Shankha banerjee	Insider - KMP	Acquisition	10.00	0.01 Cr	5,250	0.00
Nov 06, 2025	Dr. lal pathlabs employee wel...	Insider - Other	Disposal	10.00	0.01 Cr	5,750	0.00
Sep 30, 2025	Mrinal kapoor	Insider - Designated Person	Disposal	3,125.77	0.94 Cr	3,000	—
Sep 30, 2025	Dr. lal pathlabs employee wel...	Insider - Other	Disposal	731.65	0.03 Cr	450	0.00
Sep 24, 2025	Punit sharma	Insider - Designated Person	Acquisition	2,625.93	0.20 Cr	750	—

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Corporate Action

21 hours ago

Amended Trust Deed for ESOP 2025

The announcement details the execution of an amended trust deed in relation to the Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025, reflecting compliance changes per SEBI regulations.

Bonus Issue

3 days ago

Record Date Set for Bonus Equity Shares

The company has announced December 19, 2025, as the Record Date for issuing bonus equity shares in a 1:1 ratio.

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q4 FY24

Investor Presentation

Q4 FY24

Showing 1 - 8 of 40

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode